Ampa Health
Ampa Health develops the FDA-cleared Ampa One brain stimulation system to treat depression, anxiety, and addiction through scalable transcranial magnetic stimulation (TMS) technology.
Company facts
- Founded
- 2022
- Headquarters
- United States
- CEO
- Don Vaughn
About
Ampa Health is a pioneering neurotechnology company dedicated to eradicating depression and mental health disorders through scalable brain stimulation technology. The company has developed Ampa One, an FDA-cleared transcranial magnetic stimulation (TMS) system that reactivates the brain circuits responsible for courage, resilience, and mental well-being. Founded in 2022, Ampa is on a mission to help one billion people reach remission from mental and neurological disorders. The company's innovative approach transforms decades of neuroscience research into practical, accessible treatment tools. Ampa One makes TMS therapy more affordable and available than ever before - combining cutting-edge technology with a simple, lightweight, easy-to-use platform built by clinicians for clinicians. The streamlined system delivers magnetic pulses that safely and non-invasively activate brain circuits, strengthening them through neuroplasticity. With over 3 million patients having received more than 60 million TMS treatments to date, Ampa is democratizing access to next-generation mental health treatments for depression, anxiety, and addiction.